Sun Pharmaceutical Industries Ltd. closed 15.54% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...

Shares of Checkpoint Therapeutics (CKPT) have jumped $1.59, or 64%, to $4.06 in Monday morning trading after the company and Sun Pharmaceutical ...

Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC.

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...

Modalert is widely recognized for its superb capability in enhancing cognitive power, concentration, and prolonged ...

Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs like Ozempic and Wegovy, which are going off patent in India in January ...

AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements. Stocks including ONGC, Sun Pharma, IndusInd Bank, Nestle, Tata Power, Waaree Energies, IRB Infra ...

Hence, during this uncertain period, the brokerage prefers to stick to Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., and Torrent Pharma Ltd. because these companies have less ...

Sun Pharmaceutical Industries on Thursday said it has sought shareholders' approval for related-party transactions (RPTs) worth approximately $1 billion for FY26. The transactions involve Sun Pharma’s ...